Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardiometabolic diseases, ...
Neglected Tropical disease treatment market is expected to grow from an estimated USD 3614.5 million in 2024 to USD 5371.5 million in 2033, at a CAGR of 4.50% ...